We are live on ! Find out more
VFA

Values First Advisors Portfolio holdings

AUM $192M
1-Year Est. Return 24.96%
This Fund
S&P 500
This Quarter Est. Return
-10.65%
1 Year Est. Return
+24.96%
3 Year Est. Return
+70.52%
5 Year Est. Return
+87.3%
10 Year Est. Return
AUM
$141M
AUM Growth
-$17.6M
Cap. Flow
-$140K
Cap. Flow %
-0.1%
Top 10 Hldgs %
28.54%
Holding
179
New
16
Increased
76
Reduced
61
Closed
22

Sector Composition

Rank Sector Weight
1 Technology 15.85%
2 Healthcare 14.48%
3 Industrials 11.7%
4 Real Estate 7%
5 Financials 5.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NDAQ icon
126
Nasdaq
NDAQ
$51.5B
$232K 0.16%
4,563
+48
+1% +$2.54K
SSYS icon
127
Stratasys
SSYS
$697M
$227K 0.16%
12,126
-256
-2% -$5.04K
RXDX
128
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$223K 0.16%
7,907
+1,899
+32% +$55K
SNPS icon
129
Synopsys
SNPS
$71.5B
$218K 0.15%
718
+26
+4% +$7.84K
SYY icon
130
Sysco
SYY
$39.7B
$216K 0.15%
2,549
-225
-8% -$18.8K
WEC icon
131
WEC Energy
WEC
$37.7B
$215K 0.15%
+2,139
New +$217K
AAN
132
DELISTED
The Aaron's Company Inc
AAN
$214K 0.15%
14,700
-825
-5% -$15.7K
MG icon
133
Mistras Group
MG
$492M
$209K 0.15%
35,153
-2,489
-7% -$14.7K
IEX icon
134
IDEX
IEX
$16.5B
$205K 0.15%
+1,129
New +$213K
CMS icon
135
CMS Energy
CMS
$23.1B
$203K 0.14%
+3,010
New +$208K
LL
136
DELISTED
LL Flooring Holdings, Inc.
LL
$198K 0.14%
21,143
-1,136
-5% -$13.9K
LCUT icon
137
Lifetime Brands
LCUT
$199M
$194K 0.14%
17,540
-1,120
-6% -$13.2K
TLPH icon
138
Talphera
TLPH
$70.1M
$187K 0.13%
38,358
+6,232
+19% +$29K
COGT icon
139
Cogent Biosciences
COGT
$6.79B
$147K 0.1%
+16,310
New +$111K
DHC
140
Diversified Healthcare Trust
DHC
$2.26B
$143K 0.1%
78,697
-3,649
-4% -$8.34K
XBI icon
141
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$128K 0.09%
+1,720
New +$129K
LCI
142
DELISTED
Lannett Company, Inc.
LCI
$116K 0.08%
49,979
-1,968
-4% -$4.89K
ATHX
143
DELISTED
Athersys, Inc. Common Stock
ATHX
$100K 0.07%
15,312
+1,397
+10% +$15.5K
ZYME icon
144
Zymeworks
ZYME
$1.68B
$96K 0.07%
18,140
+2,205
+14% +$13.3K
IMVT icon
145
Immunovant
IMVT
$8.09B
$88K 0.06%
22,482
+9,013
+67% +$38.9K
GIFI
146
DELISTED
Gulf Island Fabrication
GIFI
$67K 0.05%
20,025
-1,228
-6% -$4.32K
PLUR icon
147
Pluri
PLUR
$19.2M
$58K 0.04%
5,853
-333
-5% -$4.1K
ROIV icon
148
Roivant Sciences
ROIV
$25.2B
$58K 0.04%
+14,200
New +$56.4K
TRML
149
DELISTED
Tourmaline Bio
TRML
$53K 0.04%
+1,168
New +$92.2K
FRLN
150
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$49K 0.03%
3,753
+410
+12% +$5.27K

Similar funds

Values First Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Values First Advisors held 179 positions worth $141M, down 11% from $158M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Values First Advisors's Q2 2022 filing shows 16 new, 76 increased, 61 reduced and 22 closed positions. Its largest new stake was Amphenol: 50,330 shares worth $1.62M. The largest sale was State Street SPDR Portfolio Mortgage Backed Bond ETF, an estimated $2.57M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Industrials.

  • Values First Advisors's largest Q2 2022 buy was Amphenol: 50,330 shares worth $1.62M.
  • Values First Advisors added most to Vanguard Short-Term Treasury ETF in Q2 2022, an estimated $2.11M increase.
  • Values First Advisors's biggest Q2 2022 reduction was State Street SPDR Portfolio Mortgage Backed Bond ETF, cutting an estimated $2.57M.
  • Values First Advisors fully exited Edwards Lifesciences in Q2 2022, selling an estimated $2.43M.
  • Values First Advisors's ten largest holdings make up 29% of its $141M portfolio in Q2 2022.
  • Values First Advisors opened 16 new positions and closed 22 in Q2 2022.
  • Values First Advisors's portfolio value fell 11% quarter-over-quarter to $141M.

Based on Values First Advisors's 13F filing for Q2 2022, filed 20 Jul 2022.